Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3490 | 1973 | 42.7 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
1064 | 2 | LONG QT SYNDROME//BRUGADA SYNDROME//QT INTERVAL | 10012 |
3490 | 1 | HERG//I KR//HERG CHANNEL | 1973 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HERG | authKW | 2725427 | 16% | 55% | 321 |
2 | I KR | authKW | 749637 | 4% | 66% | 73 |
3 | HERG CHANNEL | authKW | 729731 | 4% | 65% | 73 |
4 | HUMAN ETHER A GO GO RELATED GENE | authKW | 647027 | 3% | 75% | 56 |
5 | LONG QT SYNDROME | authKW | 488574 | 11% | 14% | 224 |
6 | TORSADES DE POINTES | authKW | 375292 | 6% | 22% | 112 |
7 | TORSADE DE POINTES | authKW | 288321 | 5% | 20% | 94 |
8 | QT PROLONGATION | authKW | 259819 | 4% | 21% | 80 |
9 | RAPID DELAYED RECTIFIER | authKW | 248455 | 1% | 94% | 17 |
10 | HUMAN ETHER A GO GO RELATED GENE HERG | authKW | 186333 | 1% | 71% | 17 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 8475 | 39% | 0% | 768 |
2 | Cardiac & Cardiovascular System | 5802 | 22% | 0% | 435 |
3 | Physiology | 2837 | 14% | 0% | 272 |
4 | Chemistry, Medicinal | 1159 | 8% | 0% | 155 |
5 | Toxicology | 900 | 7% | 0% | 140 |
6 | Peripheral Vascular Diseases | 688 | 6% | 0% | 122 |
7 | Biophysics | 572 | 7% | 0% | 142 |
8 | Biochemistry & Molecular Biology | 350 | 15% | 0% | 304 |
9 | Cell Biology | 265 | 8% | 0% | 157 |
10 | Biochemical Research Methods | 99 | 3% | 0% | 66 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | QT PRODACT | 99036 | 0% | 80% | 8 |
2 | SAFETY PHARMACOL | 95345 | 2% | 21% | 30 |
3 | MARK COWLEY LIDWILL PROGRAM CARDIAC ELE OPH | 94782 | 0% | 88% | 7 |
4 | EXCELLENCE CARDIOVASC SAFETY | 91020 | 1% | 59% | 10 |
5 | ELECT ENGN CYBERNET | 79583 | 0% | 86% | 6 |
6 | NORA ECCLES HARRISON CARDIOVASC TRAINING IN | 53929 | 2% | 12% | 30 |
7 | MOL CARDIOL BIOPHYS | 50628 | 1% | 27% | 12 |
8 | SAFETY ASSESSMENT UK | 48411 | 1% | 24% | 13 |
9 | GLOBAL PRECLIN TOXICOL PATHOL | 46425 | 0% | 100% | 3 |
10 | ECCLES PROGRAM HUMAN MOL BIOL GENET | 42852 | 1% | 21% | 13 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS | 22760 | 2% | 4% | 41 |
2 | BRITISH JOURNAL OF PHARMACOLOGY | 11031 | 6% | 1% | 113 |
3 | ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES | 10924 | 1% | 3% | 22 |
4 | JOURNAL OF PHARMACOLOGICAL SCIENCES | 7190 | 2% | 1% | 33 |
5 | HEART RHYTHM | 5028 | 2% | 1% | 31 |
6 | JOURNAL OF GENERAL PHYSIOLOGY | 4737 | 2% | 1% | 32 |
7 | MOLECULAR PHARMACOLOGY | 4378 | 3% | 1% | 53 |
8 | CARDIOVASCULAR RESEARCH | 3767 | 2% | 1% | 44 |
9 | JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 3754 | 2% | 1% | 40 |
10 | JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | 3702 | 2% | 1% | 32 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HERG | 2725427 | 16% | 55% | 321 | Search HERG | Search HERG |
2 | I KR | 749637 | 4% | 66% | 73 | Search I+KR | Search I+KR |
3 | HERG CHANNEL | 729731 | 4% | 65% | 73 | Search HERG+CHANNEL | Search HERG+CHANNEL |
4 | HUMAN ETHER A GO GO RELATED GENE | 647027 | 3% | 75% | 56 | Search HUMAN+ETHER+A+GO+GO+RELATED+GENE | Search HUMAN+ETHER+A+GO+GO+RELATED+GENE |
5 | LONG QT SYNDROME | 488574 | 11% | 14% | 224 | Search LONG+QT+SYNDROME | Search LONG+QT+SYNDROME |
6 | TORSADES DE POINTES | 375292 | 6% | 22% | 112 | Search TORSADES+DE+POINTES | Search TORSADES+DE+POINTES |
7 | TORSADE DE POINTES | 288321 | 5% | 20% | 94 | Search TORSADE+DE+POINTES | Search TORSADE+DE+POINTES |
8 | QT PROLONGATION | 259819 | 4% | 21% | 80 | Search QT+PROLONGATION | Search QT+PROLONGATION |
9 | RAPID DELAYED RECTIFIER | 248455 | 1% | 94% | 17 | Search RAPID+DELAYED+RECTIFIER | Search RAPID+DELAYED+RECTIFIER |
10 | HUMAN ETHER A GO GO RELATED GENE HERG | 186333 | 1% | 71% | 17 | Search HUMAN+ETHER+A+GO+GO+RELATED+GENE+HERG | Search HUMAN+ETHER+A+GO+GO+RELATED+GENE+HERG |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VANDENBERG, JI , PERRY, MD , PERRIN, MJ , MANN, SA , KE, Y , HILL, AP , (2012) HERG K+ CHANNELS: STRUCTURE, FUNCTION, AND CLINICAL SIGNIFICANCE.PHYSIOLOGICAL REVIEWS. VOL. 92. ISSUE 3. P. 1393 -1478 | 351 | 54% | 144 |
2 | POLAK, S , WISNIOWSKA, B , BRANDYS, J , (2009) COLLATION, ASSESSMENT AND ANALYSIS OF LITERATURE IN VITRO DATA ON HERG RECEPTOR BLOCKING POTENCY FOR SUBSEQUENT MODELING OF DRUGS' CARDIOTOXIC PROPERTIES.JOURNAL OF APPLIED TOXICOLOGY. VOL. 29. ISSUE 3. P. 183-206 | 177 | 73% | 39 |
3 | VILLOUTREIX, BO , TABOUREAU, O , (2015) COMPUTATIONAL INVESTIGATIONS OF HERG CHANNEL BLOCKERS: NEW INSIGHTS AND CURRENT PREDICTIVE MODELS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 86. ISSUE . P. 72 -82 | 118 | 73% | 11 |
4 | HANCOX, JC , MCPATE, MJ , EL HARCHI, A , ZHANG, YH , (2008) THE HERG POTASSIUM CHANNEL AND HERG SCREENING FOR DRUG-INDUCED TORSADES DE POINTES.PHARMACOLOGY & THERAPEUTICS. VOL. 119. ISSUE 2. P. 118 -132 | 144 | 69% | 94 |
5 | WANG, SC , LI, YY , XU, L , LI, D , HOU, TJ , (2013) RECENT DEVELOPMENTS IN COMPUTATIONAL PREDICTION OF HERG BLOCKAGE.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 13. ISSUE 11. P. 1317-1326 | 84 | 88% | 20 |
6 | RASCHI, E , CECCARINI, L , DE PONTI, F , RECANATINI, M , (2009) HERG-RELATED DRUG TOXICITY AND MODELS FOR PREDICTING HERG LIABILITY AND QT PROLONGATION.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 5. ISSUE 9. P. 1005-1021 | 97 | 77% | 33 |
7 | DURDAGI, S , SUBBOTINA, J , LEES-MILLER, J , GUO, J , DUFF, HJ , NOSKOV, SY , (2010) INSIGHTS INTO THE MOLECULAR MECHANISM OF HERG1 CHANNEL ACTIVATION AND BLOCKADE BY DRUGS.CURRENT MEDICINAL CHEMISTRY. VOL. 17. ISSUE 30. P. 3514 -3532 | 99 | 66% | 21 |
8 | HE, FZ , MCLEOD, HL , ZHANG, W , (2013) CURRENT PHARMACOGENOMIC STUDIES ON HERG POTASSIUM CHANNELS.TRENDS IN MOLECULAR MEDICINE. VOL. 19. ISSUE 4. P. 227-238 | 79 | 75% | 12 |
9 | ZHANG, KP , YANG, BF , LI, BX , (2014) TRANSLATIONAL TOXICOLOGY AND RESCUE STRATEGIES OF THE HERG CHANNEL DYSFUNCTION: BIOCHEMICAL AND MOLECULAR MECHANISTIC ASPECTS.ACTA PHARMACOLOGICA SINICA. VOL. 35. ISSUE 12. P. 1473 -1484 | 74 | 80% | 6 |
10 | TAN, YY , CHEN, YD , YOU, QD , SUN, HP , LI, MH , (2012) PREDICTING THE POTENCY OF HERG K+ CHANNEL INHIBITION BY COMBINING 3D-QSAR PHARMACOPHORE AND 2D-QSAR MODELS.JOURNAL OF MOLECULAR MODELING. VOL. 18. ISSUE 3. P. 1023-1036 | 73 | 83% | 16 |
Classes with closest relation at Level 1 |